OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 34 filers reported holding OCULAR THERAPEUTIX INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $76,000 | -33.3% | 12,344 | 0.0% | 0.00% | – |
| Q2 2017 | $114,000 | +10.7% | 12,344 | +10.8% | 0.00% | – |
| Q1 2017 | $103,000 | +10.8% | 11,140 | 0.0% | 0.00% | – |
| Q4 2016 | $93,000 | +20.8% | 11,140 | 0.0% | 0.00% | – |
| Q3 2016 | $77,000 | +40.0% | 11,140 | 0.0% | 0.00% | – |
| Q2 2016 | $55,000 | -40.9% | 11,140 | +15.9% | 0.00% | – |
| Q1 2016 | $93,000 | +3.3% | 9,608 | 0.0% | 0.00% | – |
| Q4 2015 | $90,000 | -54.1% | 9,608 | -31.2% | 0.00% | -100.0% |
| Q3 2015 | $196,000 | -29.0% | 13,975 | +6.5% | 0.00% | 0.0% |
| Q2 2015 | $276,000 | -26.6% | 13,119 | +46.5% | 0.00% | -50.0% |
| Q1 2015 | $376,000 | +251.4% | 8,954 | +97.3% | 0.00% | – |
| Q4 2014 | $107,000 | +345.8% | 4,539 | +178.1% | 0.00% | – |
| Q3 2014 | $24,000 | – | 1,632 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,944,761 | $23,898,000 | 100.00% |
| Opaleye Management Inc. | 5,974,800 | $24,019,000 | 10.83% |
| DELTEC ASSET MANAGEMENT LLC | 2,069,313 | $8,319,000 | 1.95% |
| Kamunting Street Capital Management, L.P. | 275,506 | $1,108,000 | 1.50% |
| Altium Capital Management LP | 695,000 | $2,794,000 | 1.12% |
| Endurant Capital Management LP | 760,228 | $3,056,000 | 1.07% |
| EMERALD ADVISERS, LLC | 1,465,702 | $5,892,000 | 0.30% |
| MSD Partners, L.P. | 1,016,302 | $4,086,000 | 0.25% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,044,732 | $4,200,000 | 0.24% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $781,000 | 0.11% |